Cansino Biologics Inc.
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China. Show More...
-
Website https://www.cansinotech.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 33.80 HKD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CNY -0.23 -0.3 -1.54 -0.77 -0.77 Dividends CNY Payout Ratio % * Shares Mil 218.0 218.0 90.0 203.0 203.0 Book Value Per Share * HKD 7.8 7.13 Free Cash Flow Per Share * HKD -1.41 Return on Assets % -15.28 -10.81 -16.64 -12.15 -12.15 Financial Leverage (Average) 1.52 1.43 1.58 1.21 1.21 Return on Equity % -23.24 -15.69 -24.92 -15.89 -15.89 Return on Invested Capital % -17.62 -12.94 -20.25 -15.41 -15.41 Interest Coverage Current Ratio 5.37 3.78 2.07 6.39 6.39 Quick Ratio 5.37 3.75 1.99 6.26 6.26 Debt/Equity 0.32 0.18 0.3 0.09 0.09